Cignar

Royce Chen, MD, is the Jean Sheng Associate Professor of Ophthalmology, Vice Chair of Education, and Residency Program Director for the Department of Ophthalmology at Columbia University Irving Medical Center. He is also an Attending Ophthalmologist at Harlem Hospital Center. Dr. Chen is a board-certified ophthalmologist who specializes in the surgical and medical management of vitreoretinal disease and uveitis. Dr. Chen graduated from Yale University with a B.A. in Music where he sang at Mory's every week with the Yale Whiffenpoofs. He received his M.D. from Tufts University School of Medicine before performing his ophthalmology residency at Columbia University, where he served as Chief Resident. This was followed by a 2-year vitreoretinal surgical fellowship at the Bascom Palmer Eye Institute at the University of Miami, where he served as a Clinical Instructor in Ophthalmology.He has received numerous honors, including the John Martin Wheeler Resident Teaching Award at Columbia, the Heed Foundation Fellowship, American Academy of Ophthalmology Achievement Award, selection into the New-York Presbyterian Leadership-Academy (LEAD), and recognition as a NYC Super Doctor. Dr. Chen has a wide range of research interests, ranging from retinal imaging, to artificial intelligence, to innovation in clinical and surgical education. In addition to his roles at Columbia, Dr. Chen also serves on the Board of Trustees and as Vice President of Trainee Mentorship for the Vit Buckle Society and as Planning Group Member for the National Eye Institute Health Education Program.

Scott E. Brodie, MD, Ph.D., is a Professor of Clinical Ophthalmology and Attending Ophthalmologist in the Department of Ophthalmology. He is an internationally known clinician-scientist, and a leader in the use of electrophysiologic techniques for diagnosing of visual impairments in children and adults.Dr. Brodie is a graduate of the combined MD-PhD program at Weill-Cornell Medical College and The Rockefeller University in New York. He completed his PhD in retinal physiology in the laboratory of Nobel Laureate H. K. Hartline, under the supervision of Dr. Floyd Ratliff and Prof. Bruce Knight. He completed a medical internship and residency training in ophthalmology at The New York Hospital, and subsequently received fellowship training in medical retinal disorders and clinical electrophysiology of vision at New York University and Bellevue Hospital under the supervision of Dr. Ronald Carr, with support as a John Kluge Fellow of the Retinitis Pigmentosa Foundation.He is a fellow of the American Academy of Ophthalmology, and a fellow of the Association for Research in Vision and Ophthalmology. He is a member of the International Society for Clinical Electrophysiology of Vision, the International Society for Genetic Eye Disease, and the Ophthalmic Genetics Study Club. Dr. Brodie has been honored with the Senior Achievement Award of the American Academy of Ophthalmology, as well as the Academy's Secretariat Award for Education.Dr. Brodie’s research centers on improving methodologies for electrophysiologic testing, and descriptions of novel findings in patients with inherited and metabolic retinal disorders. He has been a key member of the teams which have introduced important new therapies, including enzyme-replacement therapy for Fabry disease, and intra-arterial chemotherapy for retinoblastoma, which has increased the rate of salvage of diseased eyes in the most severely affected patients from 20% to over 90%.Dr. Brodie has published extensively on electrophysiology and retinal disorders. He has a particular interest in clinical optics, and has served as Chair of the Editorial committee for the American Academy of Ophthalmology’s Basic and Clinical Science Course on Clinical Optics for the past ten years. In his spare time, he enjoys reading mathematics, and playing the oboe in local orchestras and chamber groups.